TD Cowen Begins Coverage on Astrana Health (NASDAQ:ASTH)
TD Cowen started coverage on Astrana Health in a report on Monday. They issued a “buy” rating and a $66.00 target price on the stock.
Source link
Similar Posts
The biggest infrastructure spending boom in history just kicked off – Fat Tail Daily
Did governments screw up our gas supply? According to some sources in the industry, a rather similar thing happened to our electricity and water industry. Last week’s Daily Reckoning got some classy feedback…alongside the usual not so classy stuff. I asked why Australians didn’t just buy their own natural gas back when it was cheap….
Reserve Bank of India (RBI) Issues Framework for Reclassification of FPI to FDI – Equitypandit
November 11, 2024November 11, 2024 On Monday, the Reserve Bank of India issued a framework for reclassifying foreign portfolio investor (FPI) investments to foreign direct investment (FDI) if the entity exceeds the prescribed limit of 10% ownership in paid-up equity capital. If an FPI breaches the prescribed 10% limit,…
Warren Buffett’s Berkshire Hathaway tops $1 trillion market value
The market value of Berkshire Hathaway surpassed $1 trillion on Wednesday, reflecting investor confidence in the conglomerate that Warren Buffett built over nearly six decades into what many consider a proxy for the American economy. Berkshire joined six other companies, mainly from the technology sector, above $1 trillion: Apple, Nvidia , Microsoft, Google parent Alphabet,…
Can AI finally stop hallucinating? Microsoft thinks so 🤯
As generative AI (genAI) continues to grow in influence and capability, so do its challenges, particularly hallucinations—erroneous outputs… This article Can AI finally stop hallucinating? Microsoft thinks so 🤯 appeared first on Guerilla Stock Trading. Source link
TSX Today: What to Watch for in Stocks on Tuesday, March 10
After plunging by 3.7% last week due to the expanding U.S.-Israel-Iran conflict, Canadian stocks started the new week on a slightly positive note as U.S. president Donald Trump’s latest remarks suggested the military campaign against Iran may be nearing its end sooner than initially expected, which also supported a pullback in crude oil prices from…
TransMedics’ Organ Care: Critical Innovation With Lofty Expectations (NASDAQ:TMDX)
This article was written by Follow I’m a biotech and healthcare investment analyst with several years of clinical experience and a Master of Business Administration. I’ve had the privilege of sharing my analyses on Seeking Alpha since 2017. Outside of spending time with family, this is my favorite thing to do. I utilize risk-return charts…
